Table of Contents:
- 1. Epidemiology and aetiology of head and neck cancers
- 2. Head and neck cancer prevention
- 3. Cellular and molecular pathology of head and neck tumors
- 4. Oncogenomics/Proteomics of head and neck cancers
- 5. Genetics and epigenetics of head and neck cancer
- 6. Immunology of head and neck cancer
- 7. Biomarkers in head and neck cancer
- 8. HPV and EBV in head and neck cancer
- 9. Head and neck cancer staging and prognosis: perspectives of the UICC and the AJCC
- 10. Preclinical models of head and neck squamous cell carcinoma
- 11. Translational research in head and neck oncology
- 12. Hypoxia in head and neck cancers: clinical relevance and treatment
- 13. Imaging of head and neck cancers
- 14. Ultrasound investigations in head & neck cancer patients
- 15. Sentinel node biopsy
- 16. Intensity-modulated radiation therapy for head and neck cancer
- 17. Stereotactic radiotherapy in head and neck cancer patients
- 18. Proton beam therapy for head and neck cancer
- 19. Principles of systemic chemotherapy for squamous cell head and neck cancer
- 20. Molecular targeted therapies in head and neck cancer
- 21. Laser endoscopic treatment
- 22. Transoral robotic surgery in head and neck cancer
- 23. Multidisciplinary management of skull base and superstructure tumors
- 24. Multidisciplinary management of oral cavity and maxillary sinus cancers
- 25. Oral oncology
- 26. Management of nasopharyngeal carcinoma
- 27. Multidisciplinary management of oropharynx carcinomas
- 28. Multidisciplinary management of hypopharyngeal carcinoma
- 29. Cancers of the larynx: Tis, T1, T2 evaluation and management
- 30. Diagnosis and multidisciplinary treatment of laryngeal cancers
- 31. Programs of organ and function preservation
- 32. Principles and new approaches in surgical reconstruction
- 33. Multidisciplinary treatment of the neck
- 34. Postoperative management of high-risk resectable head and neck cancer
- 35. Multidisciplinary approach of unresectable head and neck cancer
- 36. Management of salivary gland cancer
- 37. Primary mucosal melanomas of the head and neck
- 38: Head & neck cutaneous melanoma
- 39. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site
- 40. The management of thyroid and parathyroid cancer
- 41. Head and neck paragangliomas
- 42. Systemic treatment of recurrent/metastatic squamous cell carcinoma of the head and neck
- 43. Phase i study methodology in head and neck oncology
- 44. Treatment of the elderly head and neck cancer patient
- 45. Normal tissue complications and protection in head and neck cancer patients
- 46. Advances in management of complications for head and neck cancer therapy
- 47. Rehabilitation of heavily treated head and neck cancer patients
- 48. Salvage therapy in head and neck cancer patients
- 49. Quality of life in head and neck cancer patients
- 50. Psycho-oncologic aspects of head and neck cancer patients
- 51. Advances in nanomedicine for head and neck cancer
- 52. Head and neck quality assurance 2014